Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets

DRUG2 trials

Sponsors

Ranbaxy Laboratories Limited

Conditions

Healthy

Unknown Phase

Bioequivalence Study of Fosinopril Sodium / Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fed Conditions

CompletedNCT00778713

Ranbaxy Laboratories LimitedHealthy

Start: 2003-03-31End: 2003-04-30Updated: 2008-10-23

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

CompletedNCT00777972

Ranbaxy Laboratories LimitedHealthy

Start: 2003-03-31End: 2003-04-30Updated: 2008-10-23